The interface of bio–nano science and cancer medicine is an area experiencing much
progress but also beset with controversy. Core concepts of the field eg, the enhanced …

Cancer continues to be among the leading healthcare problems worldwide, and efforts
continue not just to find better drugs, but also better drug delivery methods. The need for …

Remarkable progress has recently been made in the synthesis and characterization of
engineered nanoparticles for imaging and treatment of cancers, resulting in several …

The anti-tumor activity of the immune system is increasingly recognized as critical for the
mounting of a prolonged and effective response to cancer growth and invasion, and for …

Macrophages (MΦs) have the capability to sense chemotactic cues and to home tumors,
therefore presenting a great approach to engineer these cells to deliver therapeutic agents …

Abstracts A major challenge in the field of nanomedicine is to transform laboratory
innovations into commercially successful clinical products. In this campaign, a variety of …

A main goal of mathematical and computational oncology is to develop quantitative tools to
determine the most effective therapies for each individual patient. This involves predicting …

Tumors are complex multicellular heterogeneous systems comprised of components that
interact with and modify one another. Tumor development depends on multiple factors …

Over the past decades, considerable attention has been dedicated to the exploitation of
diverse immune cells as therapeutic and/or diagnostic cell‐based microrobots for hard‐to …

CD33 is an immunomodulatory receptor linked to Alzheimer's disease (AD) susceptibility via
regulation of phagocytosis in microglia. Divergent features between human CD33 (hCD33) …